Processa Pharmaceuticals
Price & Volume
Stats
See moreOpen | $1.85 |
Previous Close | $1.94 |
Day Range | $1.85-$1.86 |
52W Range | $1.04-$8.88 |
Market Cap | $5.4M |
Shares Short | 46,488 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$4.33 |
News
See moreYahoo Finance • 13 hours ago
Processa Pharmaceuticals Announces Key Leadership Appointments
Yahoo Finance • 3 months ago
PROCESSA PHARMACEUTICALS, INC. ANNOUNCES ACQUISITION OF VIDYA THERAPEUTICS, INC. AND APPROXIMATELY $200 MILLION CONCURRENT PRIVATE PLACEMENT TO ADVANCE BTK INHIBITOR, VT-7208, IN MULTIPLE DISEASE AREAS
Yahoo Finance • 5 months ago
Top Biotech Gainers: VRXA Begins A New Chapter, ADIL Opens Wallet, PGEN, PCSA On Watch...
Yahoo Finance • 11 months ago
Weekly Buzz: CYTK Scores First FDA Approval, INSM Ends Rhinosinusitis Study, XOMA Acquires GBIO
About
CEO | Mr. George K. Ng Esq., J.D. |
Address | 601 21st Street, Vero Beach, FL, United States, 32960 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 12 |